About this FactMed analysis covering adverse side effect reports of ALMARL patients who developed METAMORPHOPSIA.

FactMed provides MD-approved analysis to help both patients, researchers, and physicians accurately assess the risk profile for more than 20,000 different pharmaceutical products. The below report offers compiled information from Food & Drug Administration and FactMed user submissions. Between January 2004 and October 2012, 1 individuals taking ALMARL reported METAMORPHOPSIA to the FDA. A total of 227 ALMARL drug adverse event reaction reports were made with the FDA during this time period. Often the FDA only receives reports of the most critical and severe cases; these numbers may therefore underrepresent the complication rate of the medication.

FDA Research Report

Introduction This page is designed to help you determine the relationship, if any, between ALMARL and METAMORPHOPSIA. In doing so, we compare ALMARL with other drugs that cause METAMORPHOPSIA, to help you evaluate whether or not ALMARL causes METAMORPHOPSIA. Likewise, this page shows the most highly-reported side effects of ALMARL, so you can see if METAMORPHOPSIA ranks among ALMARL's most well-known side effects.
Summary Statistics
Reports of ALMARL causing METAMORPHOPSIA: 1
Reports of any side effect of ALMARL : 227
Percentage of ALMARL patients where METAMORPHOPSIA is a reported side effect: 0.4405%

FDA reports of any drug causing METAMORPHOPSIA : 497
Average percentage for all medicated patients where METAMORPHOPSIA is reported as a complication: 0.0031%

Physician opinion on ALMARL as adverse event culprit:

Overall opinion for all reports of this drug:
Most frequent diagnoses/indications for prescribing ALMARL:
HYPERTENSION ( 76 patients )
PARKINSON'S DISEASE ( 8 patients )
ESSENTIAL TREMOR ( 6 patients )
ATRIAL FIBRILLATION ( 4 patients )
SCHIZOPHRENIA ( 2 patients )
TREMOR ( 2 patients )
ANGINA PECTORIS ( 2 patients )
DRUG USE FOR UNKNOWN INDICATION ( 2 patients )
PALPITATIONS ( 2 patients )
PRODUCT USED FOR UNKNOWN INDICATION ( 2 patients )
TACHYCARDIA ( 2 patients )
HYPERTROPHY ( 1 patients )
( 0 patients )
Drugs with high FDA adverse event association with METAMORPHOPSIA:

RANIBIZUMAB (111 patients)
LUCENTIS (56 patients)
VISUDYNE (41 patients)
LYRICA (36 patients)
TYSABRI (35 patients)
TOPROL-XL (29 patients)
GILENYA (21 patients)
SEROQUEL (20 patients)
ASPIRIN (19 patients)
BACLOFEN (19 patients)
ESCITALOPRAM (18 patients)
MODAFINIL (17 patients)
LIPITOR (17 patients)
PREMARIN (16 patients)
FTY 720 FTY+CAP+MSC (16 patients)
PLAQUENIL (15 patients)
NEXIUM (15 patients)
AVONEX (14 patients)
PREVACID (14 patients)
FTY 720 (14 patients)
AVASTIN (13 patients)
NEURONTIN (13 patients)
OMEPRAZOLE (13 patients)
PLAVIX (13 patients)
FOLIC ACID (13 patients)
LANTUS (12 patients)
CIPRALEX (12 patients)
VERAPAMIL (12 patients)
VIAGRA (12 patients)
PREDNISONE (12 patients)
EFFEXOR XR (12 patients)
LAMICTAL (12 patients)
LISINOPRIL (11 patients)
WELLBUTRIN (11 patients)
FAMOTIDINE (11 patients)
FOSAMAX (11 patients)
LEVOTHYROXINE SODIUM (10 patients)
CALCIUM (10 patients)
NABUMETONE (10 patients)
HUMIRA (10 patients)
XALATAN (10 patients)
VITAMIN D (10 patients)
XANAX (10 patients)
FERROUS SULFATE TAB (10 patients)
AMITRIPTYLINE (9 patients)
PROTONIX (9 patients)
TOPIRAMATE (9 patients)
AVANDIA (9 patients)
WARFARIN SODIUM (9 patients)
DIGOXIN (9 patients)
ZOLOFT (9 patients)
NIACIN (8 patients)
SYNTHROID (8 patients)
TRAZODONE (8 patients)
SIMVASTATIN (8 patients)
CELLCEPT (8 patients)
CLONAZEPAM (8 patients)
MULTI-VITAMINS (8 patients)
HYDROCHLOROTHIAZIDE (8 patients)
GABAPENTIN (8 patients)
OXYCONTIN (8 patients)
HYDROCODONE (8 patients)
LIORESAL (8 patients)
VOLTAREN (7 patients)
ALBUTEROL (7 patients)
VFEND (7 patients)
VITAMIN B-12 (7 patients)
NITROGLYCERIN (7 patients)
ATENOLOL (7 patients)
BENAZEPRIL HYDROCHLORIDE (7 patients)
CYMBALTA (7 patients)
KLONOPIN (7 patients)
VIOXX (7 patients)
DOXEPIN (7 patients)
ENBREL (7 patients)
LORAZEPAM (7 patients)
VARENICLINE TARTRATE (7 patients)
FERROUS SULFATE (7 patients)
METHOTREXATE (6 patients)
ADVAIR DISKUS 100/50 (6 patients)
VITAMIN E (6 patients)
PRILOSEC (6 patients)
MORPHINE (6 patients)
AMLODIPINE BESYLATE (6 patients)
ZYPREXA (6 patients)
RESTASIS (6 patients)
GEODON (6 patients)
BENADRYL (6 patients)
BETAHISTINE HYDROCHLORIDE (6 patients)
KEPPRA (6 patients)
PROLEUKIN (6 patients)
XOPENEX (6 patients)
CELEBREX (6 patients)
CHANTIX (6 patients)
GLUCOPHAGE (6 patients)
NIASPAN (6 patients)
LEVOXYL (6 patients)
EFFEXOR (6 patients)
PROZAC (6 patients)
METFORMIN (6 patients)
FLUORESCEIN (6 patients)
TORADOL (5 patients)
VEETIDS (5 patients)
ACETAMINOPHIN (5 patients)
MACROBID (5 patients)
MIRALAX (5 patients)
TUSSIONEX (5 patients)
WARFARIN (5 patients)
METOCLOPRAMIDE (5 patients)
ALPRAZOLAM (5 patients)
PENICILLIN VK (5 patients)
ROXICET (5 patients)
AMOXIL (5 patients)
TRASTUZUMAB (5 patients)
METRONIDAZOL (5 patients)
LACTULOSE (5 patients)
NYSTATIN (5 patients)
NITROSTAT (5 patients)
BIAXIN (5 patients)
BLEPHAMIDE (5 patients)
YASMIN (5 patients)
LORTAB (5 patients)
PROPACET 100 (5 patients)
MEDROXYPR AC (5 patients)
CEPHALEXIN (5 patients)
CLORAZEPATE DIPOTASSIUM (5 patients)
NAPROSYN (5 patients)
NASACORT AQ (5 patients)
DARVOCET (5 patients)
PLETAL (5 patients)
KETOROLAC TROMETHAMINE (5 patients)
DIOVAN (5 patients)
PROPULSID (5 patients)
LIDOCAINE HCL VISCOUS (5 patients)
ZOVIRAX (5 patients)
DOXYCYCL HYC (5 patients)
PROGESTERONE (5 patients)
PROPOXYPHENE NAPSYLATE AND ACETAMINOPHEN (5 patients)
FEMHRT (5 patients)
METOPROLOL TARTRATE (5 patients)
METOPROLOL (5 patients)
FISH PIL (5 patients)
SMZ/TMP DS (5 patients)
FLUOXETINE (5 patients)
INDERAL (4 patients)
LASIX (4 patients)
ALTACE (4 patients)
AMBIEN (4 patients)
LEVITRA (4 patients)
MYCOPHENOLATE MOFETIL (4 patients)
ASCORBIC ACID (4 patients)
ISOSORBIDE MONONITRATE (4 patients)
YAZ (4 patients)
SPIRONOLACTONE (4 patients)
CILOSTAZOL (4 patients)
MORPHINE SULFATE (4 patients)
CLOPIDOGREL (4 patients)
CLORAZ DIPOT (4 patients)
METFORMIN HCL (4 patients)
COUMADIN (4 patients)
NICOTINE (4 patients)
PANTOLOC ^NYCOMED^ (4 patients)
CYTOXAN (4 patients)
HUMALOG (4 patients)
HYDROCODONE BITARTRATE AND ACETAMINOPHEN (4 patients)
PRAVASTATIN (4 patients)
ZOCOR (4 patients)
DOCUSATE (4 patients)
ZOPICLONE (4 patients)
RAMIPRIL (4 patients)
MACROLIN (4 patients)
EXJADE (4 patients)
ROBITUSSIN CHILDREN'S COUGH AND COLD LONG ACTING (4 patients)
FLONASE (4 patients)
MELATONIN (4 patients)
FLUORESCEIN SODIUM (4 patients)
TAXOTERE (4 patients)
ACETAZOLAMIDE (3 patients)
TRUVADA (3 patients)
ACTONEL (3 patients)
ACYCLOVIR (3 patients)
TIZANIDINE HCL (3 patients)
SOMNOTE (3 patients)
ANTIBIOTICS (3 patients)
ANTIHYPERTENSIVES (3 patients)
AROMASIN (3 patients)
THYROID (UNK INGREDIENTS) (3 patients)
PROPOXYPHENE HCL CAP (3 patients)
REBIF (3 patients)
CARDIZEM (3 patients)
SINGULAIR (3 patients)
SPIRIVA (3 patients)
CHAMPIX (3 patients)
CIPROFLOXACIN (3 patients)
TRAZODONE HCL (3 patients)
TOPAMAX (3 patients)
MULTIVITAMIN (3 patients)
TOVIAZ (3 patients)
TRIAMCINOLONE (3 patients)
COLCHICINE (3 patients)
NAFTOPIDIL (3 patients)
PREZISTA (3 patients)
LOTENSIN (3 patients)
RELAFEN (3 patients)
REQUIP (3 patients)
FISH OIL (3 patients)
SEROXAT (3 patients)
FLUTICASONE PROPIONATE (3 patients)
SUDAFED 12 HOUR (3 patients)
FORTEO (3 patients)
Most common side effects for patients taking ALMARL:
DEPRESSED LEVEL OF CONSCIOUSNESS (20 patients)
HALLUCINATION (15 patients)
FALL (13 patients)
HYPOGLYCAEMIA (13 patients)
PYREXIA (12 patients)
TREMOR (12 patients)
DIARRHOEA (11 patients)
HEPATIC FUNCTION ABNORMAL (11 patients)
PNEUMONIA (10 patients)
DYSARTHRIA (10 patients)
BLOOD CREATINE PHOSPHOKINASE INCREASED (9 patients)
RENAL FAILURE ACUTE (9 patients)
LIVER DISORDER (9 patients)
CEREBRAL INFARCTION (8 patients)
DISSEMINATED INTRAVASCULAR COAGULATION (8 patients)
DRUG INEFFECTIVE (8 patients)
RENAL IMPAIRMENT (8 patients)
HYPONATRAEMIA (8 patients)
INTERSTITIAL LUNG DISEASE (8 patients)
JAUNDICE (8 patients)
OEDEMA PERIPHERAL (8 patients)
CONDITION AGGRAVATED (7 patients)
DELIRIUM (7 patients)
DYSPHAGIA (7 patients)
DYSPNOEA (7 patients)
HYPOAESTHESIA (7 patients)
RHABDOMYOLYSIS (7 patients)
VOMITING (6 patients)
DELUSION (6 patients)
RESPIRATORY FAILURE (6 patients)
DYSKINESIA (6 patients)
SOMNOLENCE (6 patients)
HEPATIC NEOPLASM MALIGNANT (6 patients)
HYPERGLYCAEMIA (6 patients)
HYPOKALAEMIA (6 patients)
MOVEMENT DISORDER (6 patients)
MUSCULAR WEAKNESS (6 patients)
WHITE BLOOD CELL COUNT INCREASED (5 patients)
BLADDER CANCER (5 patients)
BLOOD ANTIDIURETIC HORMONE INCREASED (5 patients)
RESTLESSNESS (5 patients)
BLOOD OSMOLARITY DECREASED (5 patients)
PLEURAL EFFUSION (5 patients)
C-REACTIVE PROTEIN INCREASED (5 patients)
CONVULSION (5 patients)
RENAL DISORDER (5 patients)
VITH NERVE PARALYSIS (5 patients)
INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION (5 patients)
INTESTINAL OBSTRUCTION (5 patients)
SEPSIS (5 patients)
ROAD TRAFFIC ACCIDENT (5 patients)
MUSCULOSKELETAL PAIN (5 patients)
NAUSEA (5 patients)
ANOREXIA (4 patients)
ATELECTASIS (4 patients)
ATRIAL FIBRILLATION (4 patients)
ATRIOVENTRICULAR BLOCK (4 patients)
BLOOD CREATININE INCREASED (4 patients)
BRADYCARDIA (4 patients)
CARDIAC FAILURE (4 patients)
CONSTIPATION (4 patients)
DECREASED APPETITE (4 patients)
DEHYDRATION (4 patients)
DIZZINESS (4 patients)
PLATELET COUNT DECREASED (4 patients)
PAIN (4 patients)
HYPERTENSION (4 patients)
HYPOTHYROIDISM (4 patients)
ILEUS (4 patients)
METABOLIC ACIDOSIS (4 patients)
SMALL INTESTINE CARCINOMA (4 patients)
URINE OSMOLARITY INCREASED (4 patients)
ABASIA (3 patients)
AGGRESSION (3 patients)
PRURITUS (3 patients)
ANAEMIA (3 patients)
PULMONARY ALVEOLAR HAEMORRHAGE (3 patients)
WHITE BLOOD CELL COUNT DECREASED (3 patients)
ASTHMA (3 patients)
BLOOD BILIRUBIN INCREASED (3 patients)
RENAL FAILURE (3 patients)
BLOOD PRESSURE DECREASED (3 patients)
BLOOD PRESSURE INCREASED (3 patients)
VASCULITIS (3 patients)
CAROTID ARTERY STENOSIS (3 patients)
THERAPEUTIC AGENT TOXICITY (3 patients)
CHILLS (3 patients)
CHROMATURIA (3 patients)
PETECHIAE (3 patients)
CHRONIC LYMPHOCYTIC LEUKAEMIA (3 patients)
PORIOMANIA (3 patients)
RENAL ARTERY STENOSIS (3 patients)
PANCYTOPENIA (3 patients)
DRUG ERUPTION (3 patients)
SUDDEN ONSET OF SLEEP (3 patients)
DRUG WITHDRAWAL SYNDROME (3 patients)
VERTIGO (3 patients)
EPILEPSY (3 patients)
FACE OEDEMA (3 patients)
VOLVULUS (3 patients)
GENERALISED OEDEMA (3 patients)
GINGIVAL BLEEDING (3 patients)
HAEMORRHAGE SUBCUTANEOUS (3 patients)
HALLUCINATION, VISUAL (3 patients)
PSYCHIATRIC SYMPTOM (3 patients)
HEART RATE DECREASED (3 patients)
HELICOBACTER TEST POSITIVE (3 patients)
HEPATITIS FULMINANT (3 patients)
HYPERKALAEMIA (3 patients)
HYPOTENSION (3 patients)
IDIOPATHIC THROMBOCYTOPENIC PURPURA (3 patients)
LOSS OF CONSCIOUSNESS (3 patients)
SENSORY DISTURBANCE (3 patients)
LYMPHOMA (3 patients)
MALAISE (3 patients)
MARKEDLY REDUCED DIETARY INTAKE (3 patients)
RENAL TUBULAR DISORDER (3 patients)
NEOPLASM MALIGNANT (3 patients)
SINUS ARREST (3 patients)
ABDOMINAL DISCOMFORT (2 patients)
ABDOMINAL PAIN (2 patients)
ACUTE MYELOID LEUKAEMIA (2 patients)
STOMACH MASS (2 patients)
PERSONALITY CHANGE (2 patients)
AGITATION (2 patients)
ALTERED STATE OF CONSCIOUSNESS (2 patients)
ANAPHYLACTOID REACTION (2 patients)
ANGER (2 patients)
PRODUCTIVE COUGH (2 patients)
RENAL CYST (2 patients)
APHASIA (2 patients)
ASTHENIA (2 patients)
ATRIOVENTRICULAR BLOCK COMPLETE (2 patients)
THIRST (2 patients)
PROSTATE CANCER (2 patients)
BLOOD AMYLASE INCREASED (2 patients)
BLOOD UREA INCREASED (2 patients)
BODY TEMPERATURE INCREASED (2 patients)
SPEECH DISORDER (2 patients)
TUMOUR LYSIS SYNDROME (2 patients)
CEREBRAL HAEMORRHAGE (2 patients)
CHEST X-RAY ABNORMAL (2 patients)
COLON CANCER (2 patients)
COMA HEPATIC (2 patients)
COMPLETED SUICIDE (2 patients)
CONTUSION (2 patients)
PERFORMANCE STATUS DECREASED (2 patients)
DEFAECATION URGENCY (2 patients)
DEMENTIA ALZHEIMER'S TYPE (2 patients)
RASH PRURITIC (2 patients)
DIABETIC KETOACIDOSIS (2 patients)
DRUG INTERACTION (2 patients)
DRUG LEVEL INCREASED (2 patients)
DYSPEPSIA (2 patients)
DYSSTASIA (2 patients)
ELECTROCARDIOGRAM QT PROLONGED (2 patients)
STEVENS-JOHNSON SYNDROME (2 patients)
EPULIS (2 patients)
EXTRAOCULAR MUSCLE PARESIS (2 patients)
FACIAL PARESIS (2 patients)
FEAR (2 patients)
FEBRILE NEUTROPENIA (2 patients)
FEMORAL NECK FRACTURE (2 patients)
FOOT FRACTURE (2 patients)
GAMMA-GLUTAMYLTRANSFERASE INCREASED (2 patients)
GANGRENE (2 patients)
GASTRIC ULCER HAEMORRHAGE (2 patients)
GINGIVAL HYPERTROPHY (2 patients)
GLOSSOPTOSIS (2 patients)
PLEURISY (2 patients)
PHRENIC NERVE PARALYSIS (2 patients)
HAEMATEMESIS (2 patients)
HAEMATURIA (2 patients)
HAEMOGLOBIN DECREASED (2 patients)
POLLAKIURIA (2 patients)
ORAL INTAKE REDUCED (2 patients)
HEPATIC CYST (2 patients)
HEPATIC ENCEPHALOPATHY (2 patients)
HEPATITIS (2 patients)
HYPERREFLEXIA (2 patients)
HYPERTONIA (2 patients)
HYPERURICAEMIA (2 patients)
RASH PAPULAR (2 patients)
INITIAL INSOMNIA (2 patients)
RETINAL OEDEMA (2 patients)
INTESTINAL FUNCTIONAL DISORDER (2 patients)
RESPIRATION ABNORMAL (2 patients)
IRRITABILITY (2 patients)
RIB FRACTURE (2 patients)
LEG AMPUTATION (2 patients)
LYMPHADENOPATHY (2 patients)
METABOLIC ALKALOSIS (2 patients)
ORAL HERPES (2 patients)
TAKAYASU'S ARTERITIS (2 patients)
MOUTH HAEMORRHAGE (2 patients)
UNRESPONSIVE TO STIMULI (2 patients)
TOXIC SKIN ERUPTION (2 patients)
NEPHROLITHIASIS (2 patients)
SUICIDE ATTEMPT (2 patients)
VENTRICULAR FIBRILLATION (2 patients)
NEUTROPHIL COUNT DECREASED (2 patients)
UPPER RESPIRATORY TRACT INFECTION (2 patients)
UPPER GASTROINTESTINAL HAEMORRHAGE (2 patients)
SHOCK HAEMORRHAGIC (2 patients)
ABDOMEN CRUSHING (1 patients)
CARDIAC FAILURE CONGESTIVE (1 patients)
EOSINOPHILIC PNEUMONIA ACUTE (1 patients)
ESSENTIAL TREMOR (1 patients)
WRONG TECHNIQUE IN DRUG USAGE PROCESS (1 patients)
FUNGAL INFECTION (1 patients)

In addition to reviewing our up-to-date FDA research, users may interact with the FactMed community - currently one million members and growing! FactMed online research and discussions are read by patients, scientists, physicians, and other interested health care parties. Post follow up Questions to learn from our diverse readership. Likewise, patients who have experienced unwanted effects are encouraged to share their Concerns to help educate and inform our members.


Recent FactMed Activity for ALMARL


Issue Description / Topic Timestamp

My Patient Resources

Get your questions answered! Over one million patients, researchers, and health care providers have visited FactMed. If you have a question about METAMORPHOPSIA and ALMARL, post it here. You may receive a response from a fellow patient - or a leading expert in the field.
Your Question:

Share your experience: Over one million patients, researchers, and health care providers have visited FactMed. If you have a noteworthy experience as a patient taking ALMARL, post it here. Your story could help a fellow patient - or provide insight to a leading expert in the field.
Your Experience or Concern:

Telemedicine Expert Consults FactMed newest feature allows patients to consult - via realtime videoconferencing - experts in ALMARL. This premium feature connects patients to experts, regardless of geography. FactMed experts charge reasonable rates that may be reimbursable by your insurance as a second-opinion.
We are currently accepting registration for ALMARL experts. If you are a healthcare provider experienced in prescribing ALMARL, please register here.

Your online appointment book for Crookston Rentals & Services

Chef and Catering services in Crookston
Chiropracter and Massage services in Crookston
Event and Wedding Planning services in Crookston
Hair Styling services in Crookston
Personal Shopping services in Crookston
Photography and Videography services in Crookston
Private Investigation services in Crookston
Website Design services in Crookston

Home
Appliance Repair services in Crookston
Appraisals services in Crookston
Awnings services in Crookston
Builder Services services in Crookston
Carpentry services in Crookston
Cleaning services in Crookston
Decks and Porches services in Crookston
Electricians services in Crookston
Fireplace services in Crookston
Generators services in Crookston
Greenhouses and Nurseries services in Crookston
Handymen services in Crookston
Home Security services in Crookston
HVAC services in Crookston
Insulation services in Crookston
Interior Design services in Crookston
Landscaping services in Crookston
Lawn and Yard services in Crookston
Locksmiths services in Crookston
Marble and Granite Experts services in Crookston
Masonry services in Crookston
Moving Services services in Crookston
Painters services in Crookston
Plumbing services in Crookston
Pool and Spa services in Crookston
Property Management services in Crookston
Roofers services in Crookston
Snow Plowing services in Crookston
Solar Power Consultants services in Crookston
Upholstery services in Crookston
Wallpaper services in Crookston
Waterproofing services in Crookston
Windows services in Crookston
Services - Other

© 2014 FactMed, Inc
Privacy Policy
Terms of Use